Skip to main content
. 2021 Apr 23;11:8863. doi: 10.1038/s41598-021-88346-w

Figure 5.

Figure 5

Effect of ulipristal or/and metformin on ERα and PR expression of rats’ uteri. (AD) photomicrographs of uteri show expression of ERα. (A) Uterine wall in the control group. (B) Uterine wall in ulipristal treated group. (C) Uterine wall in metformin treated group. (D) Uterine wall in the ulipristal and metformin treated group. × 400 magnification (scale bar = 20 μm). (E) Expression quantification of the optical density reactivity of positive cells of ERα by the ImageJ analysis system. (FI) photomicrographs of uteri shows expression of PR. (F) Uterine wall in the control group. (G) Uterine wall in ulipristal treated group. (H) Uterine wall in metformin treated group. (I) Uterine wall in ulipristal and metformin treated group. × 400 magnification (scale bar = 20 μm). (J) Expression quantification of the optical density reactivity of positive cells of PR by the ImageJ analysis system. Data in figures (E) and (J) is represented by mean ± SD (n = 7). a or b, Statistically significant from the control or ulipristal and metformin treated group respectively at P < 0.05 using one-way ANOVA followed by Tukey as a post hoc test. UPA ulipristal, MET metformin, UPA + MET co-treatment with ulipristal and metformin.